Health
Scientists use new technique to study the effects of reactive electrophilic drugs – News-Medical.net
In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative…
In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple sclerosis, inflammation damages the protective myelin…
Continue Reading
-
General9 hours agoEmergency services winch man to safety in Great Ocean Road cliff rescue
-
General13 hours agoSocceroos name 26-man squad for World Cup qualifier against Japan in Perth
-
Noosa News21 hours agoBiodiversity at Bowra | Noosa Today
-
Noosa News18 hours agoPassenger killed in car and ute crash on dirt road in north Queensland